Although RIG-I-deficient hepatoma cells have been shown to produce low levels of IL-1β during HCV infection [40], we found that HCV infection of immune-competent hepatoma cells and primary hepatocytes does not trigger appreciable production of IL-1β. The gene discussed is RIGI; the disease is hepatocellular carcinoma.